LUPIN
Quarterly Results Analysis [Sep2024]
LUPIN Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹5,673 Cr | ₹5,600 Cr | ₹4,961 Cr | ₹5,197 Cr | ₹5,039 Cr | ₹4,814 Cr | ₹4,430 Cr | ₹4,322 Cr |
Expenses | ₹4,332 Cr | ₹4,359 Cr | ₹3,964 Cr | ₹4,175 Cr | ₹4,121 Cr | ₹3,958 Cr | ₹3,852 Cr | ₹3,806 Cr |
Operating Income | ₹1,340 Cr | ₹1,241 Cr | ₹997 Cr | ₹1,022 Cr | ₹918 Cr | ₹856 Cr | ₹578 Cr | ₹516 Cr |
Other Income | ₹42 Cr | ₹68 Cr | ₹29 Cr | ₹45 Cr | ₹40 Cr | ₹23 Cr | ₹37 Cr | ₹35 Cr |
Interest | ₹71 Cr | ₹68 Cr | ₹71 Cr | ₹74 Cr | ₹81 Cr | ₹86 Cr | ₹93 Cr | ₹84 Cr |
Depreciation | ₹257 Cr | ₹248 Cr | ₹457 Cr | ₹257 Cr | ₹248 Cr | ₹235 Cr | ₹264 Cr | ₹220 Cr |
Profit Before Tax | ₹1,055 Cr | ₹993 Cr | ₹498 Cr | ₹736 Cr | ₹630 Cr | ₹559 Cr | ₹259 Cr | ₹246 Cr |
Profit After Tax | ₹859 Cr | ₹806 Cr | ₹368 Cr | ₹619 Cr | ₹495 Cr | ₹453 Cr | ₹242 Cr | ₹158 Cr |
EPS | ₹18.69 | ₹17.57 | ₹7.89 | ₹13.46 | ₹10.76 | ₹9.94 | ₹5.19 | ₹3.37 |
Industry Peers & Returns | 1W | 1M | 1Y |
LUPIN | 3.7% | -4.8% | 65.6% |
SUN PHARMACEUTICAL INDUSTRIES | 2.8% | -2.7% | 50.6% |
CIPLA | 2.9% | -1.2% | 25.5% |
DR REDDYS LABORATORIES | 2.1% | -3.9% | 6.9% |
ZYDUS LIFESCIENCES | 3.3% | -2% | 53.5% |
DIVIS LABORATORIES | 3.5% | 5.4% | 67.6% |
MANKIND PHARMA | 0.1% | -4% | 37.8% |
TORRENT PHARMACEUTICALS | 4.3% | 5% | 59.6% |
AUROBINDO PHARMA | 3.5% | -9.3% | 22.9% |
LUPIN Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 1.29 % |
Y-o-Y | 12.59 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹5,673 Cr | 1.29 | |
Jun2024 | ₹5,600 Cr | 12.89 | |
Mar2024 | ₹4,961 Cr | -4.55 | |
Dec2023 | ₹5,197 Cr | 3.15 | |
Sep2023 | ₹5,039 Cr | 4.66 | |
Jun2023 | ₹4,814 Cr | 8.67 | |
Mar2023 | ₹4,430 Cr | 2.50 | |
Dec2022 | ₹4,322 Cr | - |
LUPIN Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 8.01 % |
Y-o-Y | 46.05 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹1,340 Cr | 8.01 | |
Jun2024 | ₹1,241 Cr | 24.50 | |
Mar2024 | ₹997 Cr | -2.47 | |
Dec2023 | ₹1,022 Cr | 11.35 | |
Sep2023 | ₹918 Cr | 7.18 | |
Jun2023 | ₹856 Cr | 48.21 | |
Mar2023 | ₹578 Cr | 11.96 | |
Dec2022 | ₹516 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 6.63 % |
Y-o-Y | 29.76 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 23.63% | 6.63 | |
Jun2024 | 22.16% | 10.30 | |
Mar2024 | 20.09% | 2.19 | |
Dec2023 | 19.66% | 7.96 | |
Sep2023 | 18.21% | 2.36 | |
Jun2023 | 17.79% | 36.43 | |
Mar2023 | 13.04% | 9.21 | |
Dec2022 | 11.94% | - |
LUPIN Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 6.70 % |
Y-o-Y | 73.52 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹859 Cr | 6.70 | |
Jun2024 | ₹806 Cr | 118.77 | |
Mar2024 | ₹368 Cr | -40.48 | |
Dec2023 | ₹619 Cr | 24.91 | |
Sep2023 | ₹495 Cr | 9.26 | |
Jun2023 | ₹453 Cr | 87.03 | |
Mar2023 | ₹242 Cr | 53.75 | |
Dec2022 | ₹158 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 5.35 % |
Y-o-Y | 54.12 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 15.15 % | 5.35 | |
Jun2024 | 14.38 % | 93.80 | |
Mar2024 | 7.42 % | -37.65 | |
Dec2023 | 11.9 % | 21.06 | |
Sep2023 | 9.83 % | 4.35 | |
Jun2023 | 9.42 % | 72.21 | |
Mar2023 | 5.47 % | 49.86 | |
Dec2022 | 3.65 % | - |
LUPIN Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 6.37 % |
Y-o-Y | 73.70 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹18.69 | 6.37 | |
Jun2024 | ₹17.57 | 122.69 | |
Mar2024 | ₹7.89 | -41.38 | |
Dec2023 | ₹13.46 | 25.09 | |
Sep2023 | ₹10.76 | 8.25 | |
Jun2023 | ₹9.94 | 91.52 | |
Mar2023 | ₹5.19 | 54.01 | |
Dec2022 | ₹3.37 | - |
You may also like the below Video Courses